Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ALNY crawled date : 2021 - 12 - 14 save search
Alnylam Submits Regulatory Applications to the U.S. Food and Drug Administration and European Medicines Agency to Support Label Expansion for OXLUMO® for the Treatment of Advanced Primary Hyperoxaluria Type 1
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
ALNY | $145.23 -1.02% -1.03% 500K
|
Health Technology
|
| O: 6.02%
H: 2.03%
C: -0.29%
oxlumo treatment europe application expansion drug food
New Results from Phase 1 Study of Cemdisiran + Pozelimab Presented at ASH Annual Meeting 2021
Published: 2021-12-14 (Crawled : 03:00) - alnylam.com
ALNY | $145.23 -1.02% -1.03% 500K
|
Health Technology
|
| O: 6.02%
H: 2.03%
C: -0.29%
phase 1 results phase 2 phase 3
New Long-Term Results for GIVLAARI® (givosiran) Presented at ASH Annual Meeting & Exposition
Published: 2021-12-13 (Crawled : 00:00) - alnylam.com
ALNY | $145.23 -1.02% -1.03% 500K
|
Health Technology
|
| O: 6.02%
H: 2.03%
C: -0.29%
givlaari results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.